189 related articles for article (PubMed ID: 25135000)
1. Role of toll-like receptors in cervical, endometrial and ovarian cancers: a review.
Husseinzadeh N; Davenport SM
Gynecol Oncol; 2014 Nov; 135(2):359-63. PubMed ID: 25135000
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Toll-like receptor transcriptome in squamous cell carcinoma of cervix: A case-control study.
Aggarwal R; Misra S; Guleria C; Suri V; Mangat N; Sharma M; Nijhawan R; Minz R
Gynecol Oncol; 2015 Aug; 138(2):358-62. PubMed ID: 26024767
[TBL] [Abstract][Full Text] [Related]
3. mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review.
Husseinzadeh N; Husseinzadeh HD
Gynecol Oncol; 2014 May; 133(2):375-81. PubMed ID: 24556063
[TBL] [Abstract][Full Text] [Related]
4. Expression of integrins and Toll-like receptors in cervical cancer: effect of infectious agents.
Werner J; Decarlo CA; Escott N; Zehbe I; Ulanova M
Innate Immun; 2012 Feb; 18(1):55-69. PubMed ID: 21239458
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in malignancies of the female genital tract.
Abulafia O; Triest WE; Sherer DM
Gynecol Oncol; 1999 Feb; 72(2):220-31. PubMed ID: 10021305
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironment.
DeCarlo CA; Rosa B; Jackson R; Niccoli S; Escott NG; Zehbe I
Clin Dev Immunol; 2012; 2012():785825. PubMed ID: 22013487
[TBL] [Abstract][Full Text] [Related]
7. Expression of mRNA of SCC antigen in squamous cells.
Takeshima N; Suminami Y; Takeda O; Abe H; Okuno N; Kato H
Tumour Biol; 1992; 13(5-6):338-42. PubMed ID: 1290029
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy in gynecologic malignancies. Ovarian, cervical, and endometrial cancer.
Curtin JP; Shapiro F
Surg Oncol Clin N Am; 1997 Oct; 6(4):813-30. PubMed ID: 9309095
[TBL] [Abstract][Full Text] [Related]
9. The role of Toll-like receptor 4 signaling pathway in ovarian, cervical, and endometrial cancers.
Lupi LA; Cucielo MS; Silveira HS; Gaiotte LB; Cesário RC; Seiva FRF; de Almeida Chuffa LG
Life Sci; 2020 Apr; 247():117435. PubMed ID: 32081661
[TBL] [Abstract][Full Text] [Related]
10. Association between Toll-like receptor and tumor necrosis factor immunological pathways in uterine cervical neoplasms.
de Matos LG; Cândido EB; Vidigal PV; Bordoni PH; Lamaita RM; Carneiro MM; da Silva-Filho AL
Tumori; 2017 Jan; 103(1):81-86. PubMed ID: 28009429
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells.
Green TL; Santos MF; Ejaeidi AA; Craft BS; Lewis RE; Cruse JM
Exp Mol Pathol; 2014 Aug; 97(1):44-8. PubMed ID: 24836676
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptors in human papillomavirus infection.
Zhou Q; Zhu K; Cheng H
Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):203-15. PubMed ID: 23435874
[TBL] [Abstract][Full Text] [Related]
13. Continuous low-dose GM-CSF as salvage therapy in refractory recurrent breast or female genital tract carcinoma.
Kurbacher CM; Kurbacher JA; Cramer EM; Rhiem K; Mallman PK; Reichelt R; Reinhold U; Stier U; Cree IA
Oncology (Williston Park); 2005 Apr; 19(4 Suppl 2):23-6. PubMed ID: 15934497
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori induces increased expression of Toll-like receptors and decreased Toll-interacting protein in gastric mucosa that persists throughout gastric carcinogenesis.
Pimentel-Nunes P; Gonçalves N; Boal-Carvalho I; Afonso L; Lopes P; Roncon-Albuquerque R; Henrique R; Moreira-Dias L; Leite-Moreira AF; Dinis-Ribeiro M
Helicobacter; 2013 Feb; 18(1):22-32. PubMed ID: 23061653
[TBL] [Abstract][Full Text] [Related]
15. Immunological aspects of gynecological malignancies.
DiSaia PJ
J Reprod Med; 1975 Jan; 14(1):17-20. PubMed ID: 1110478
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of Toll-like receptors in human endometrial epithelial cell lines.
Aboussahoud W; Aflatoonian R; Bruce C; Elliott S; Ward J; Newton S; Hombach-Klonisch S; Klonisch T; Fazeli A
J Reprod Immunol; 2010 Jan; 84(1):41-51. PubMed ID: 19959241
[TBL] [Abstract][Full Text] [Related]
17. The role of toll-like receptors (TLRs) and their therapeutic applications in endometrial cancer.
Arabian S; Boostan A; Darzi S
Clin Transl Oncol; 2023 Apr; 25(4):859-865. PubMed ID: 36374404
[TBL] [Abstract][Full Text] [Related]
18. [Development of tumor vaccine on gynecologic cancer].
Xu BL; Li Y; Cui H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):487-91. PubMed ID: 12974100
[TBL] [Abstract][Full Text] [Related]
19. Clinical statistics of gynecologic cancers in Japan.
Yamagami W; Nagase S; Takahashi F; Ino K; Hachisuga T; Aoki D; Katabuchi H
J Gynecol Oncol; 2017 Mar; 28(2):e32. PubMed ID: 28198168
[TBL] [Abstract][Full Text] [Related]
20. Menstrual cycle influences Toll-like receptor responses.
Dennison U; McKernan DP; Scully P; Clarke G; Cryan J; Dinan T
Neuroimmunomodulation; 2012; 19(3):171-9. PubMed ID: 22262081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
